{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:35:21Z","timestamp":1791293721522,"version":"4.1.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sandooq Al Watan","award":["SWARD-F22-013 awarded August 30th, 2022."],"award-info":[{"award-number":["SWARD-F22-013 awarded August 30th, 2022."]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Attempts to subtype, type 2 diabetes (T2D) have mostly focused on newly diagnosed European patients. In this study, our aim was to subtype T2D in a non-white Emirati ethnic population with long-standing disease, using unsupervised soft clustering, based on etiological determinants.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>The Auto Cluster model in the IBM SPSS Modeler was used to cluster data from 348 Emirati patients with long-standing T2D. Five predictor variables (fasting blood glucose (FBG), fasting serum insulin (FSI), body mass index (BMI), hemoglobin A1c (HbA1c) and age at diagnosis) were used to determine the appropriate number of clusters and their clinical characteristics. Multinomial logistic regression was used to validate clustering results.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Five clusters were identified; the first four matched Ahlqvist et al subgroups: severe insulin-resistant diabetes (SIRD), severe insulin-deficient diabetes (SIDD), mild age-related diabetes (MARD), mild obesity-related diabetes (MOD), and a fifth new subtype of mild early onset diabetes (MEOD). The Modeler algorithm allows for soft assignments, in which a data point can be assigned to multiple clusters with different probabilities. There were 151 patients (43%) with membership in cluster peaks with no overlap. The remaining 197 patients (57%) showed extensive overlap between clusters at the base of distributions.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Despite the complex picture of long-standing T2D with comorbidities and complications, our study demonstrates the feasibility of identifying subtypes and their underlying causes. While clustering provides valuable insights into the architecture of T2D subtypes, its application to individual patient management would remain limited due to overlapping characteristics. Therefore, integrating simplified, personalized metabolic profiles with clustering holds greater promise for guiding clinical decisions than subtyping alone.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0304036","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T18:19:57Z","timestamp":1716920397000},"page":"e0304036","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Etiologies underlying subtypes of long-standing type 2 diabetes"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8177-8129","authenticated-orcid":true,"given":"Riad","family":"Bayoumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Farooqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatheya","family":"Alawadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hassanein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Osama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debasmita","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Abdul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Sulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5618-6930","authenticated-orcid":true,"given":"Stafny","family":"Dsouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Mulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayha","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouza","family":"AlSharhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8518-3066","authenticated-orcid":true,"given":"Amar","family":"Khamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"key":"pone.0304036.ref001","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/1573399811666150416122903","article-title":"Heterogeneity of Pre-diabetes and Type 2 Diabetes: Implications for Prediction, Prevention and Treatment Responsiveness","volume":"12","author":"K Faerch","year":"2016","journal-title":"Curr Diabetes Rev"},{"key":"pone.0304036.ref002","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2337\/cd22-as01","article-title":"Standards of Medical Care in Diabetes-2022 Abridged for Primary Care Providers","volume":"40","author":"American Diabetes Association","year":"2022","journal-title":"Clin Diabetes"},{"key":"pone.0304036.ref003","doi-asserted-by":"crossref","first-page":"107915","DOI":"10.1016\/j.diabres.2019.107915","article-title":"Epidemiology of diabetes phenotypes and prevalent cardiovascular risk factors and diabetes complications in the National Health and Nutrition Examination Survey 2003\u20132014","volume":"158","author":"MP Bancks","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"pone.0304036.ref004","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2337\/db12-0373","article-title":"Inherited \u03b2-cell dysfunction in lean individuals with type 2 diabetes","volume":"61","author":"AE Mathews","year":"2012","journal-title":"Diabetes"},{"key":"pone.0304036.ref005","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.2337\/db14-0318","article-title":"Genetic evidence for a normal-weight \"metabolically obese\" phenotype linking insulin resistance, hypertension, coronary artery disease, and type 2 diabetes","volume":"63","author":"H Yaghootkar","year":"2014","journal-title":"Diabetes"},{"key":"pone.0304036.ref006","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S2213-8587(16)00082-6","article-title":"Phenotypes of prediabetes and stratification of cardiometabolic risk","volume":"4","author":"N Stefan","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"pone.0304036.ref007","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2147\/DMSO.S331654","article-title":"Personalized Type 2 Diabetes Management: An Update on Recent Advances and Recommendations","volume":"15","author":"DM Williams","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"key":"pone.0304036.ref008","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00125-017-4210-x","article-title":"Painting a new picture of personalised medicine for diabetes","volume":"60","author":"MI McCarthy","year":"2017","journal-title":"Diabetologia"},{"key":"pone.0304036.ref009","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s43856-023-00360-3","article-title":"Precision subclassification of type 2 diabetes: a systematic review","volume":"3","author":"S Misra","year":"2023","journal-title":"Commun Med (Lond)"},{"issue":"311","key":"pone.0304036.ref010","first-page":"311ra174","article-title":"Identification of type 2 diabetes subgroups through topological analysis of patient similarity","volume":"7","author":"L Li","year":"2015","journal-title":"Sci Transl Med"},{"key":"pone.0304036.ref011","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"E Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"pone.0304036.ref012","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1007\/s00125-021-05490-8","article-title":"Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study","volume":"64","author":"RC Slieker","year":"2021","journal-title":"Diabetologia"},{"key":"pone.0304036.ref013","doi-asserted-by":"crossref","first-page":"e002731","DOI":"10.1136\/bmjdrc-2021-002731","article-title":"Type 2 diabetes classification: a data-driven cluster study of the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) cohort","volume":"10","author":"DH Christensen","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"key":"pone.0304036.ref014","doi-asserted-by":"crossref","first-page":"e1002654","DOI":"10.1371\/journal.pmed.1002654","article-title":"Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis","volume":"15","author":"MS Udler","year":"2018","journal-title":"PLOS Med"},{"key":"pone.0304036.ref015","doi-asserted-by":"crossref","first-page":"100477","DOI":"10.1016\/j.xcrm.2021.100477","article-title":"Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: an IMI DIRECT study","volume":"3","author":"A Wesolowska-Andersen","year":"2022","journal-title":"Cell Rep Med"},{"key":"pone.0304036.ref016","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/s41591-022-01790-7","article-title":"Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes","volume":"28","author":"ATN Nair","year":"2022","journal-title":"Nat Med"},{"key":"pone.0304036.ref017","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00125-022-05848-6","article-title":"High-throughput genetic clustering of type 2 diabetes loci reveals heterogeneous mechanistic pathways of metabolic disease","volume":"66","author":"H Kim","year":"2023","journal-title":"Diabetologia"},{"key":"pone.0304036.ref018","first-page":"58","article-title":"New and unique clusters of Type 2 diabetes identified in Indians","volume":"69","author":"RM Anjana","year":"2021","journal-title":"J Assoc Physicians India"},{"key":"pone.0304036.ref019","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1038\/s41467-022-34754-z","article-title":"Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population","volume":"13","author":"SB Zaghlool","year":"2022","journal-title":"Nat Commun"},{"key":"pone.0304036.ref020","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1111\/dom.14767","article-title":"Type 2 diabetes subgroups and response to glucose-lowering therapy: results from the EDICT and Qatar studies","volume":"24","author":"T Abdul-Ghani","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"pone.0304036.ref021","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.mayocp.2023.01.024","article-title":"Subtypes of Type 2 diabetes and incident cardiovascular disease risk: UK Biobank and all of us cohorts","volume":"98","author":"Q Xue","year":"2023","journal-title":"Mayo Clin Proc"},{"key":"pone.0304036.ref022","doi-asserted-by":"crossref","first-page":"155514","DOI":"10.1016\/j.metabol.2023.155514","article-title":"Subtypes of type 2 diabetes and their association with outcomes in Korean adults\u2014A cluster analysis of community-based prospective cohort","volume":"141","author":"YC Hwang","year":"2023","journal-title":"Metabolism"},{"key":"pone.0304036.ref023","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2213-8587(19)30187-1","article-title":"Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study","volume":"7","author":"OP Zaharia","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"pone.0304036.ref024","doi-asserted-by":"crossref","first-page":"617628","DOI":"10.3389\/fendo.2021.617628","article-title":"Clinical Characteristics and Risk of Diabetic Complications in Data-Driven Clusters Among Type 2 Diabetes","volume":"12","author":"L Xing","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Suppl 2","key":"pone.0304036.ref025","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.2337\/dc09-S301","article-title":"Defining and characterizing the progression of type 2 diabetes","volume":"32","author":"VA Fonseca","year":"2009","journal-title":"Diabetes Care"},{"key":"pone.0304036.ref026","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1093\/aje\/kws440","article-title":"Risk factors for type 2 diabetes mellitus preceded by \u03b2-cell dysfunction, insulin resistance, or both in older adults: the cardiovascular Health Study","volume":"177","author":"F Imamura","year":"2013","journal-title":"Am J Epidemiol"},{"key":"pone.0304036.ref027","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2337\/dc14-0396","article-title":"\u03b2-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment","volume":"37","author":"PA Halban","year":"2014","journal-title":"Diabetes Care"},{"key":"pone.0304036.ref028","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1080\/00325481.2020.1771047","article-title":"Beta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications","volume":"132","author":"C Wysham","year":"2020","journal-title":"Postgrad Med"},{"key":"pone.0304036.ref029","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/jdi.13576","article-title":"\u03b2-Cell failure in diabetes: Common susceptibility and mechanisms shared between type 1 and type 2 diabetes","volume":"12","author":"H Ikegami","year":"2021","journal-title":"J Diabetes Investig"},{"key":"pone.0304036.ref030","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"DR Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"pone.0304036.ref031","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S2213-8587(18)30124-4","article-title":"Novel diabetes subgroups","volume":"6","author":"M van Smeden","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"pone.0304036.ref032","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S2213-8587(19)30087-7","article-title":"Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data","volume":"7","author":"JM Dennis","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"pone.0304036.ref033","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.2337\/dbi20-0002","article-title":"Precision Medicine in Type 2 Diabetes: Using Individualized Prediction Models to Optimize Selection of Treatment","volume":"69","author":"JM Dennis","year":"2020","journal-title":"Diabetes"},{"key":"pone.0304036.ref034","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2337\/diacare.26.11.2999","article-title":"Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth","volume":"26","author":"TA Hillier","year":"2003","journal-title":"Diabetes Care"},{"key":"pone.0304036.ref035","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4239\/wjd.v6.i4.613","article-title":"Lean diabetes mellitus: An emerging entity in the era of obesity","volume":"6","author":"AM George","year":"2015","journal-title":"World J Diabetes"},{"key":"pone.0304036.ref036","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/joim.13082","article-title":"Ethnic differences in adiposity and diabetes risk\u2014insights from genetic studies","volume":"288","author":"H Yaghootkar","year":"2020","journal-title":"J Intern Med"},{"key":"pone.0304036.ref037","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3390\/ijms24010658","article-title":"Current knowledge on the pathophysiology of lean\/normal-weight Type 2 diabetes","volume":"24","author":"T Salvatore","year":"2022","journal-title":"Int J Mol Sci"},{"key":"pone.0304036.ref038","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"pone.0304036.ref039","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.4239\/wjd.v12.i10.1778","article-title":"Utility of oral glucose tolerance test in predicting type 2 diabetes following gestational diabetes: towards personalized care","volume":"12","author":"RAL Bayoumi","year":"2021","journal-title":"World J Diabetes"},{"key":"pone.0304036.ref040","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00512.2019","article-title":"Type 2 diabetes: one disease, many pathways","volume":"319","author":"J Ha","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"pone.0304036.ref041","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.2337\/db05-1200","article-title":"Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study","volume":"55","author":"MA Abdul-Ghani","year":"2006","journal-title":"Diabetes"},{"key":"pone.0304036.ref042","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"WC Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"pone.0304036.ref043","doi-asserted-by":"crossref","first-page":"3061620","DOI":"10.1155\/2018\/3061620","article-title":"Future roadmaps for precision medicine applied to diabetes: rising to the challenge of heterogeneity","volume":"2018","author":"P Bowman","year":"2018","journal-title":"J Diabetes Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0304036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T18:20:21Z","timestamp":1716920421000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0304036"}},"subtitle":[],"editor":[{"given":"Yee Gary","family":"Ang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0304036","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]}}}